Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-Müllerian hormone levels in patients with turner syndrome: Relation to karyotype, spontaneous puberty, and replacement therapy.

American journal of medical genetics. Part A - 1 Sept 2018

Hamza Rasha T, Mira Marwa F, Hamed Amira I, Ezzat Treiz, Sallam Mahmoud T

Abstract excerpt

Most girls with Turner syndrome (TS) suffer from incomplete sexual development, premature ovarian failure, and infertility due to abnormal ovarian folliculogenesis. Serum anti-Müllerian hormone (AMH) levels reflect the ovarian reserve in females, even in childhood. Thus, we aimed to assess serum AMH levels in girls with TS and its relation to karyotype, spontaneous puberty, and growth hormone (GH) therapy. Fifty...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Mullerian Hormone
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hormone Replacement Therapy

Share to Karyotype

Share to Menarche

Share to Puberty

Share to ROC Curve

Share to Turner Syndrome

Source

Identifiers

PMID: 30088853
DOI: 10.1002/ajmg.a.40473

Genes

AMH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-Müllerian hormone levels in patients with turner syndrome: Relation to karyotype, spontaneous puberty, and replacement therapy.PMID 30088853Read ↗

Anti-Mullerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatmentSemantic proximity Read ↗

Serum Levels of Anti-Müllerian Hormone as a Marker of Ovarian Function in 926 Healthy Females from Birth to Adulthood and in 172 Turner Syndrome PatientsSemantic proximity Read ↗

AMH and other markers of ovarian function in patients with Turner syndrome – a single center experience of transition from pediatric to gynecological follow upSemantic proximity Read ↗

Karyotype-phenotype associations in turner syndrome: a multicenter retrospective cohort study.Semantic proximity Read ↗

FSH, LH, inhibin B and estradiol levels in Turner syndrome depend on age and karyotype: longitudinal study of 70 Turner girls with or without spontaneous pubertySemantic proximity Read ↗

Fertility preservation in Turner syndrome: Karyotype does not predict ovarian response to stimulationSemantic proximity Read ↗

Anti-Müllerian Hormone Level Determinants among Non-Polycystic-Ovary-Syndrome Women Undergoing In Vitro Fertilization: A Retrospective Cross-Sectional StudySemantic proximity Read ↗

Navigating fertility dilemmas across the lifespan in girls with Turner syndrome—a scoping reviewSemantic proximity Read ↗

Anti-Mullerian Hormone:<i>Above and Beyond Conventional Ovarian Reserve Markers</i>Semantic proximity Read ↗

Why Treat girls with Turner Syndrome with Growth Hormone? Growth and Beyond.Semantic proximity Read ↗

Anti-Müllerian Hormone in Female ReproductionSemantic proximity Read ↗

Anti-Müllerian hormone (AMH): regulator and marker of ovarian function.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.